ARDS (Moderate or Severe)NCT06878313
Role of Elastic Power in Acute Respiratory Distress Syndrome
An observational study of ARDS (Moderate or Severe) and Adult Patients, run by Hospital El Cruce.
Trial summary
Mechanical ventilation is essential for managing acute respiratory distress syndrome (ARDS), but it can also cause ventilator-induced lung injury (VILI) due to mechanical forces. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- ARDS (Moderate or Severe), Adult Patients
- How many people
- 20 participants
- Where
- No sites listed yet
- Study dates
- 1 Apr 2025to 1 Jul 2026
- How long will I take part?
- 28 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients (≥18 years) with moderate-to-severe acute respiratory distress syndrome (ARDS) included in UCI.
Inclusion Criteria: Adult patients (≥18 years) with moderate-to-severe acute respiratory distress syndrome (ARDS), as defined by the Berlin criteria, were prospectively and consecutively included.
-
Exclusion Criteria: Patients were excluded if they met at least one of the following criteria:
- History of emphysema, asthma, or pneumothorax.
- Severe instability at the time of the study preventing the PEEP titration maneuver, defined by at least one of the following indicators: SaO₂ ≤ 90%, shock requiring >0.5 γ/kg/min of norepinephrine, complex arrhythmia, myocardial ischemia, or intracranial hypertension refractory to initial treatment.
- Patients with do-not-resuscitate orders and pregnant women.
About this study
Mechanical ventilation is essential for managing acute respiratory distress syndrome (ARDS), but it can also cause ventilator-induced lung injury (VILI) due to mechanical forces. VILI results from the interaction between lung structure and mechanical ventilation factors, such as tidal volume, plateau pressure, driving pressure, inspiratory flow, respiratory rate, and PEEP. Intrinsic factors like lung heterogeneity further increase the risk.
Elastic power (EP), a key component, is linked to repetitive alveolar stretching and disease progression.
Read more
Study Objectives:
Examine the correlation between elastic power and pulmonary hyperinflation. Compare EP's sensitivity and specificity with other overdistension markers like driving pressure, plateau pressure, upper inflection point, and compliance.
Read the detailed description
Introduction:
Mechanical ventilation is a fundamental intervention in the management of acute respiratory distress syndrome (ARDS), providing life support while the lungs recover. However, it can also induce ventilator-induced lung injury (VILI) due to the mechanical forces applied during ventilation.
VILI arises from the interaction between lung structure-mainly composed of elastin and collagen fibers embedded in a hydrated extracellular matrix-and the mechanical factors imposed by ventilation. Among these, tidal volume (Vt), plateau pressure (PPlat), driving pressure (∆P), inspiratory flow (Ṹ), respiratory rate (RR), and, in certain cases, positive end-expiratory pressure (PEEP) have been identified as key determinants of lung injury. Additionally, intrinsic factors such as lung heterogeneity and reduced ventilatory capacity may increase the risk of VILI even under protective ventilation strategies.
The positive pressure generated by mechanical ventilation is distributed between the lungs and the thoracic cage. The pressure applied directly to the lungs is known as transpulmonary pressure (Ptp), defined as the difference between alveolar pressure and pleural or esophageal pressure. Ptp expands the alveoli until it balances the tension of the alveolar wall, which opposes this expansion. Alveolar wall tension directly depends on the surface tension of the liquid lining the alveoli. Under normal conditions, pulmonary surfactant reduces alveolar surface tension. However, in ARDS, inflammation and alveolar damage degrade and inhibit surfactant production, increasing surface tension, promoting alveolar collapse and stiffness.
Although the terms "pressure" and "tension" may seem synonymous, the relationship between intra-alveolar pressure and alveolar wall tension is non-linear, as described by Laplace's law:
Tension= Pressure × Radius / 2 × Thickness
This implies that, under the same Ptp, ventral alveoli (larger and with thinner walls) experience greater deformation and tension than dorsal alveoli (smaller and with thicker walls). In this context, if alveolar deformation exceeds the structural tolerance threshold, it can lead to microfractures, pulmonary edema, hemorrhage, and inflammatory activation, contributing to multiple organ dysfunction and increased mortality.
Although alveolar tension cannot be directly measured in clinical settings, tools such as computed and electrical impedance tomography allow for indirect estimation of alveolar overdistension risk. Without airflow, alveolar tension varies between a baseline value-determined by PEEP-and a maximum value at end-inspiration-defined by PPlat. Thus, lung stress can be expressed as:
Stress (ΔPtp)= Ptp at end-inspiration-Ptp at end-expiration\text
However, lung stress and strain are static variables that do not fully capture the dynamic changes occurring during the ventilatory cycle. Animal studies have shown that VILI correlates with flow magnitude, suggesting that higher deformation rates reduce the alveolus's ability to adapt. This phenomenon is described by the Kelvin-Voigt equation for viscoelastic materials:
Stress= k × Strain + η × Strain Rate
where k represents the Young's modulus of elasticity and η the viscosity modulus.
Since VILI results from a combination of pressure, volume, and flow, mechanical power emerges as an integrative concept that expresses these variables in terms of energy per unit of time. It is estimated that a mechanical power exceeding 12 J/min surpasses the lung's adaptive capacity, increasing the risk of VILI and mortality in ARDS. Among its components, elastic power (EP) is responsible for repetitive alveolar stretching and appears to be most directly associated with ARDS severity.
Study Objectives:
- To evaluate whether elastic power correlates with pulmonary hyperinflation.
- To compare the sensitivity and specificity of elastic power with other overdistension markers, such as driving pressure (∆P), plateau pressure (PPlat), the upper inflection point of the V/P curve, and respiratory system compliance (CRS).
Materials and Methods:
Ethical Considerations: The study requires evaluation and subsequent approval from the institution's ethics and research committee, following the principles established in the Declaration of Helsinki. The study was registered on ClinicalTrials.gov before patient inclusion. Inclusion in the study requires prior informed consent authorization from an adult family member.
Inclusion Criteria: Adult patients (≥18 years) with moderate to severe ARDS, according to the Berlin expert consensus definition, will be prospectively and consecutively included.
Exclusion Criteria: Patients will be excluded if they meet any of the following criteria:
History of emphysema, asthma, or pneumothorax. Severe instability at the time of the study that would prevent the recruitment maneuver, defined by at least one of the following indicators: SaO2 ≤ 90%, shock requiring more than 0.5 γ/kg/min of norepinephrine, complex arrhythmia, myocardial ischemia, or intracranial hypertension unresponsive to first-line measures.
Patients with do-not-resuscitate orders or pregnant women. Procedure: Under deep sedation and analgesia (Cambridge-Ramsay: V to VI) and using neuromuscular blocking agents, patients will be ventilated in the supine position using a ventilator (SERVO-s, Maquet, Germany) in volume control mode (VCV) with a tidal volume of 6 ml/kg of predicted body weight (PBW), a respiratory rate of 18 breaths per minute, and a constant flow.
After performing a gentle aspiration of airway secretions using a closed circuit, PEEP titration will begin stepwise, increasing in increments of 2 cmH2O starting from 8 cmH2O (baseline condition), progressively increasing until a maximum of 20 cmH2O or a plateau pressure of 45 cmH2O is reached, whichever occurs first.
At each PEEP level, respiratory mechanics, vital parameters, and impedance tomography images will be evaluated after a short stabilization period of the studied variables.
Finally, after determining the optimal PEEP based on the best respiratory system compliance (CRS), PEEP will be titrated 2 cmH2O above its optimal value to prevent alveolar derecruitment and improve patient safety.
Criteria for Stopping the Procedure: These include SaO2 below 85%, complex arrhythmias, or hemodynamic instability (mean arterial pressure <60 mmHg).
Measurement of Transpulmonary Pressures: Since direct measurement of pleural pressure (Ppl) is complicated in clinical practice, esophageal pressure (Pes) was used as a surrogate. An inflatable balloon catheter will be inserted into the lower third of the esophagus while the patient remains in the supine position, according to standard technique. The balloon will be inflated with the minimum volume of air necessary to ensure accurate pressure recordings.
Transpulmonary pressure (Ptp) measurements will be obtained using a respiratory mechanics monitoring system (FluxMed GrT, Buenos Aires, Argentina).
Electrical Impedance Tomography (EIT): EIT is a medical imaging technology that detects impedance changes through specific image algorithms by applying low-intensity electrical currents and measuring surface voltages via electrodes placed around the chest.
In this study, continuous signal recording will be performed using the commercial device with 32 electrodes, Infivision ET1000 (Infivision Medical Imaging Technology Co., Ltd., Beijing, China). This device allows non-invasive assessment of both ventilation and perfusion in four lung regions of interest (ROIs), defined by horizontal lines within the thoracic contour: ROI 1 (ventral), ROI 2 (central ventral), ROI 3 (central dorsal), and ROI 4 (dorsal).
Perfusion signals will be extracted using frequency domain filtering techniques. By analyzing the signal spectrum, the cardiac signal (which occurs at higher frequencies than the respiratory signal) will be isolated using a digital bandpass filter. Areas identified as hyperinflated will be quantified as a percentage relative to the respective ROI.
Evaluation of Elastic Power:
Elastic Power (EP): EP = 0.098 × RR × [(Vt × PEEP) + (Vt × ΔP) / 2].
- Conditions
- ARDS (Moderate or Severe), Adult Patients
- Keywords
- ARDS, VILI, Mechanical Ventilation
- Medical subject headings
- Lymphoma, Follicular
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison between pulmonary hyperinflation and pulmonary elastic power
Measured: 1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2025
- Study start1 Apr 2025 (estimated)
- Primary completion1 Apr 2026 (estimated)
- Study completion1 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for ARDS (Moderate or Severe)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
- Target duration
- 28 Days
Sponsor and investigators
- Lead sponsor
- Hospital El Cruce
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nestor Pistillo, Hospital El Cruce
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06878313
- Sponsor's protocol ID
- UTIA El Cruce
- Status last verified
- Mar 2025
- First submitted
- 11 Mar 2025
- Last updated
- 14 Mar 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Xie Y, Shi J, Liu S, Chen X, Wang Y, Li X, Yan Y. Association of elastic power in mechanical ventilation with the severity of acute respiratory distress syndrome: a retrospective study. Eur J Med Res. 2024 Jan 3;29(1):5. doi: 10.1186/s40001-023-01577-7.
PubMed 38173033Modesto I Alapont V, Aguar Carrascosa M, Medina Villanueva A. Stress, strain and mechanical power: Is material science the answer to prevent ventilator induced lung injury? Med Intensiva (Engl Ed). 2019 Apr;43(3):165-175. doi: 10.1016/j.medin.2018.06.008. Epub 2018 Nov 5. No abstract available. English, Spanish.
PubMed 30409677Marini JJ, Thornton LT, Rocco PRM, Crooke PS. From pressure to tension: a model of damaging inflation stress. Crit Care. 2023 Nov 15;27(1):441. doi: 10.1186/s13054-023-04675-4.
PubMed 37968744Gattinoni L, Marini JJ, Collino F, Maiolo G, Rapetti F, Tonetti T, Vasques F, Quintel M. The future of mechanical ventilation: lessons from the present and the past. Crit Care. 2017 Jul 12;21(1):183. doi: 10.1186/s13054-017-1750-x.
PubMed 28701178
Study at a glance
From the registry record, last updated by the sponsor on 14 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Elastic Power in Acute Respiratory Distress Syndrome
- ClinicalTrials.gov ID
- NCT06878313
- Acronym / sponsor ID
- UTIA El Cruce
- Conditions
- ARDS (Moderate or Severe), Adult Patients
- Keywords
- ARDS, VILI, Mechanical Ventilation
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Hospital El CruceUniversity, hospital or other
- Study start
- 1 Apr 2025 (estimated)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 Jul 2026 (estimated)
- First posted
- 14 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Mechanical ventilation is essential for managing acute respiratory distress syndrome (ARDS), but it can also cause ventilator-induced lung injury (VILI) due to mechanical forces. VILI results from the interaction between lung structure and mechanical ventilation factors, such as tidal volume, plateau pressure, driving pressure, inspiratory flow, respiratory rate, and PEEP. Intrinsic factors like lung heterogeneity further increase the risk.
Elastic power (EP), a key component, is linked to repetitive alveolar stretching and disease progression.
Study Objectives:
Examine the correlation between elastic power and pulmonary hyperinflation. Compare EP's sensitivity and specificity with other overdistension markers like driving pressure, plateau pressure, upper inflection point, and compliance.
Detailed description
Introduction:
Mechanical ventilation is a fundamental intervention in the management of acute respiratory distress syndrome (ARDS), providing life support while the lungs recover. However, it can also induce ventilator-induced lung injury (VILI) due to the mechanical forces applied during ventilation.
VILI arises from the interaction between lung structure-mainly composed of elastin and collagen fibers embedded in a hydrated extracellular matrix-and the mechanical factors imposed by ventilation. Among these, tidal volume (Vt), plateau pressure (PPlat), driving pressure (∆P), inspiratory flow (Ṹ), respiratory rate (RR), and, in certain cases, positive end-expiratory pressure (PEEP) have been identified as key determinants of lung injury. Additionally, intrinsic factors such as lung heterogeneity and reduced ventilatory capacity may increase the risk of VILI even under protective ventilation strategies.
The positive pressure generated by mechanical ventilation is distributed between the lungs and the thoracic cage. The pressure applied directly to the lungs is known as transpulmonary pressure (Ptp), defined as the difference between alveolar pressure and pleural or esophageal pressure. Ptp expands the alveoli until it balances the tension of the alveolar wall, which opposes this expansion. Alveolar wall tension directly depends on the surface tension of the liquid lining the alveoli. Under normal conditions, pulmonary surfactant reduces alveolar surface tension. However, in ARDS, inflammation and alveolar damage degrade and inhibit surfactant production, increasing surface tension, promoting alveolar collapse and stiffness.
Although the terms "pressure" and "tension" may seem synonymous, the relationship between intra-alveolar pressure and alveolar wall tension is non-linear, as described by Laplace's law:
Tension= Pressure × Radius / 2 × Thickness
This implies that, under the same Ptp, ventral alveoli (larger and with thinner walls) experience greater deformation and tension than dorsal alveoli (smaller and with thicker walls). In this context, if alveolar deformation exceeds the structural tolerance threshold, it can lead to microfractures, pulmonary edema, hemorrhage, and inflammatory activation, contributing to multiple organ dysfunction and increased mortality.
Although alveolar tension cannot be directly measured in clinical settings, tools such as computed and electrical impedance tomography allow for indirect estimation of alveolar overdistension risk. Without airflow, alveolar tension varies between a baseline value-determined by PEEP-and a maximum value at end-inspiration-defined by PPlat. Thus, lung stress can be expressed as:
Stress (ΔPtp)= Ptp at end-inspiration-Ptp at end-expiration\text
However, lung stress and strain are static variables that do not fully capture the dynamic changes occurring during the ventilatory cycle. Animal studies have shown that VILI correlates with flow magnitude, suggesting that higher deformation rates reduce the alveolus's ability to adapt. This phenomenon is described by the Kelvin-Voigt equation for viscoelastic materials:
Stress= k × Strain + η × Strain Rate
where k represents the Young's modulus of elasticity and η the viscosity modulus.
Since VILI results from a combination of pressure, volume, and flow, mechanical power emerges as an integrative concept that expresses these variables in terms of energy per unit of time. It is estimated that a mechanical power exceeding 12 J/min surpasses the lung's adaptive capacity, increasing the risk of VILI and mortality in ARDS. Among its components, elastic power (EP) is responsible for repetitive alveolar stretching and appears to be most directly associated with ARDS severity.
Study Objectives:
- To evaluate whether elastic power correlates with pulmonary hyperinflation.
- To compare the sensitivity and specificity of elastic power with other overdistension markers, such as driving pressure (∆P), plateau pressure (PPlat), the upper inflection point of the V/P curve, and respiratory system compliance (CRS).
Materials and Methods:
Ethical Considerations: The study requires evaluation and subsequent approval from the institution's ethics and research committee, following the principles established in the Declaration of Helsinki. The study was registered on ClinicalTrials.gov before patient inclusion. Inclusion in the study requires prior informed consent authorization from an adult family member.
Inclusion Criteria: Adult patients (≥18 years) with moderate to severe ARDS, according to the Berlin expert consensus definition, will be prospectively and consecutively included.
Exclusion Criteria: Patients will be excluded if they meet any of the following criteria:
History of emphysema, asthma, or pneumothorax. Severe instability at the time of the study that would prevent the recruitment maneuver, defined by at least one of the following indicators: SaO2 ≤ 90%, shock requiring more than 0.5 γ/kg/min of norepinephrine, complex arrhythmia, myocardial ischemia, or intracranial hypertension unresponsive to first-line measures.
Patients with do-not-resuscitate orders or pregnant women. Procedure: Under deep sedation and analgesia (Cambridge-Ramsay: V to VI) and using neuromuscular blocking agents, patients will be ventilated in the supine position using a ventilator (SERVO-s, Maquet, Germany) in volume control mode (VCV) with a tidal volume of 6 ml/kg of predicted body weight (PBW), a respiratory rate of 18 breaths per minute, and a constant flow.
After performing a gentle aspiration of airway secretions using a closed circuit, PEEP titration will begin stepwise, increasing in increments of 2 cmH2O starting from 8 cmH2O (baseline condition), progressively increasing until a maximum of 20 cmH2O or a plateau pressure of 45 cmH2O is reached, whichever occurs first.
At each PEEP level, respiratory mechanics, vital parameters, and impedance tomography images will be evaluated after a short stabilization period of the studied variables.
Finally, after determining the optimal PEEP based on the best respiratory system compliance (CRS), PEEP will be titrated 2 cmH2O above its optimal value to prevent alveolar derecruitment and improve patient safety.
Criteria for Stopping the Procedure: These include SaO2 below 85%, complex arrhythmias, or hemodynamic instability (mean arterial pressure <60 mmHg).
Measurement of Transpulmonary Pressures: Since direct measurement of pleural pressure (Ppl) is complicated in clinical practice, esophageal pressure (Pes) was used as a surrogate. An inflatable balloon catheter will be inserted into the lower third of the esophagus while the patient remains in the supine position, according to standard technique. The balloon will be inflated with the minimum volume of air necessary to ensure accurate pressure recordings.
Transpulmonary pressure (Ptp) measurements will be obtained using a respiratory mechanics monitoring system (FluxMed GrT, Buenos Aires, Argentina).
Electrical Impedance Tomography (EIT): EIT is a medical imaging technology that detects impedance changes through specific image algorithms by applying low-intensity electrical currents and measuring surface voltages via electrodes placed around the chest.
In this study, continuous signal recording will be performed using the commercial device with 32 electrodes, Infivision ET1000 (Infivision Medical Imaging Technology Co., Ltd., Beijing, China). This device allows non-invasive assessment of both ventilation and perfusion in four lung regions of interest (ROIs), defined by horizontal lines within the thoracic contour: ROI 1 (ventral), ROI 2 (central ventral), ROI 3 (central dorsal), and ROI 4 (dorsal).
Perfusion signals will be extracted using frequency domain filtering techniques. By analyzing the signal spectrum, the cardiac signal (which occurs at higher frequencies than the respiratory signal) will be isolated using a digital bandpass filter. Areas identified as hyperinflated will be quantified as a percentage relative to the respective ROI.
Evaluation of Elastic Power:
Elastic Power (EP): EP = 0.098 × RR × [(Vt × PEEP) + (Vt × ΔP) / 2].
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 28 Days
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients (≥18 years) with moderate-to-severe acute respiratory distress syndrome (ARDS) included in UCI.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Comparison between pulmonary hyperinflation and pulmonary elastic power
Time frame: 1 hour
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Mar 2025.
- Results publication: PubMed 38173033Xie Y, Shi J, Liu S, Chen X, Wang Y, Li X, Yan Y. Association of elastic power in mechanical ventilation with the severity of acute respiratory distress syndrome: a retrospective study. Eur J Med Res. 2024 Jan 3;29(1):5. doi: 10.1186/s40001-023-01577-7.
- Results publication: PubMed 30409677Modesto I Alapont V, Aguar Carrascosa M, Medina Villanueva A. Stress, strain and mechanical power: Is material science the answer to prevent ventilator induced lung injury? Med Intensiva (Engl Ed). 2019 Apr;43(3):165-175. doi: 10.1016/j.medin.2018.06.008. Epub 2018 Nov 5. No abstract available. English, Spanish.
- Results publication: PubMed 37968744Marini JJ, Thornton LT, Rocco PRM, Crooke PS. From pressure to tension: a model of damaging inflation stress. Crit Care. 2023 Nov 15;27(1):441. doi: 10.1186/s13054-023-04675-4.
- Results publication: PubMed 28701178Gattinoni L, Marini JJ, Collino F, Maiolo G, Rapetti F, Tonetti T, Vasques F, Quintel M. The future of mechanical ventilation: lessons from the present and the past. Crit Care. 2017 Jul 12;21(1):183. doi: 10.1186/s13054-017-1750-x.
- Individual participant dataSharing planned: No
Related trials for ARDS (Moderate or Severe)
RecruitingPhase 2
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Acute Respiratory Distress Syndrome, Infections
Active, not recruitingPhase 1/2
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome
Recruiting
Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS
ARDS (Moderate or Severe)
Recruiting
STimulation to Activate RespIration
ARDS (Moderate or Severe), AHRF
RecruitingEarly Phase 1
A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
ARDS (Moderate or Severe), ARDS (Acute Respiratory Distress Syndrome)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of ARDS (Moderate or Severe) and Adult Patients, run by Hospital El Cruce.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 14 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison between pulmonary hyperinflation and pulmonary elastic power (time frame: 1 hour). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06878313, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2025.